Search

Learn more about HPV and cancer risk in the Hispanic community, which has more cancers linked to the disease than any other group in the United States.

… Tuesday, February 19, 2019 The vaccine against the human papillomavirus (HPV) has proven to be a remarkably potent weapon for preventing several kinds of cancer. But experts believe that far too few people are getting the vaccine. That leaves many people exposed to cancers that could be prevented. This

Obtenga más información acerca del VPH y del riesgo de contraer cáncer en la comunidad hispana, que es la que tiene más casos de cáncer vinculado con la enfermedad en comparación con todos los demás grupos de los Estados Unidos.

… Tuesday, February 19, 2019 Resumen Un especialista de MSK explica por qué el VPH provoca más cáncer entre los hispanos que entre cualquier otro grupo, y cómo el hecho de hacer que más personas se vacunen contra el virus puede mejorar la salud pública. La vacuna contra el virus del papiloma humano (VPH

Leadership and staff from Memorial Sloan Kettering Cancer Center (MSK) joined leaders from New York Cancer & Blood Specialists (NYCBS) and Memorial Medical Care, PC (MMC), a practice of MSK physicians, to celebrate the recent opening of a new cancer care practice in the Flatbush section of Brooklyn.

… Wednesday, April 19, 2023 In early April, leadership and staff from Memorial Sloan Kettering Cancer Center (MSK) joined leaders from New York Cancer & Blood Specialists (NYCBS) and Memorial Medical Care, PC (MMC), a practice of MSK physicians, to celebrate the recent opening of a new cancer care practice

New insights into the way cells break away from a tissue during embryonic development may also shed new light on the same process in the context of cancer metastasis.

… Wednesday, May 10, 2023 Cancer’s ability to spread throughout the body — a process known as metastasis — is responsible for the vast majority of cancer deaths. And a key feature of metastasis is that the cancer cells move, breaking away from a primary tumor and travelling to distant parts of the body

Research conducted in zebrafish shows that melanoma cells have an affinity for fat, and that eating it makes them more aggressive.

… Thursday, June 14, 2018 Summary Researchers at the Sloan Kettering Institute have discovered that melanoma cells in zebrafish use fat from nearby fat cells to fuel their growth and spread. Cancer cells get hungry. Very hungry. It takes a lot of energy to reproduce the way they do — repeatedly and often

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

… Thursday, December 1, 2011 Summary German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma. Cancer biologist Hans-Guido Wendel trained as a physician in Germany, but research

… Tuesday, May 5, 2026 Student Research Six students make the transition from students to scientists as they begin their dissertation research. Eric Alonzo Eric Alonzo — Elucidating the role of PLZF in gd T cell development Our lab has recently shown that the Promyelocytic Leukemia Zinc Finger (PLZF) gene

Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully treated many people for lung cancer.

… Friday, November 1, 2024 If you have been diagnosed with lung cancer, where you go first matters — and so does knowing what questions to ask your care team. There have been remarkable strides in understanding and treating lung cancer over the past two decades, from better screening procedures to lifesaving

Conozca las preguntas que debe hacerle a un médico especialista en cáncer pulmonar después de recibir el diagnóstico, de la mano de un especialista de MSK que ha tratado con éxito a muchas personas con cáncer pulmonar.

… Friday, November 1, 2024 Si le han diagnosticado cáncer pulmonar, es importante a dónde acudir en primer lugar. También es importante saber qué preguntas hacerle a su equipo de atención médica. En las últimas dos décadas se han logrado avances notables en la comprensión y el tratamiento del cáncer pulmonar

The first-ever clinical trial of a new kind of drug, called pirtobrutinib or LOXO-305, has shown promising results in a phase I/II study.

… Friday, March 5, 2021 Summary Pirtobrutinib (also known as LOXO-305), a type of drug called a BTK inhibitor, appears to be effective in many people with blood cancers called B cell malignancies. The incidence of severe side effects for the drug is also very low. The first-ever clinical trial of a new